Based upon the mortality findings in the ADRENAL trial, do you routinely consider use of hydrocortisone in patients with refractory shock in clinical practice? | NEJM Resident 360

@NEJMres360 Journal Club: Hosted by Yale University Internal Medicine Residency Program on Adjunctive Glucocorticoid Therapy in Patients with Septic Shock, and Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

Q&A has ended

Authors
Jeremy Cohen, MD, PhD

Senior Staff Specialist at Royal Brisbane and Women's Hospital

Jeremy Cohen, MD, PhD

Jeremy Cohen, MD, PhD

Senior Staff Specialist at Royal Brisbane and Women's Hospital

Senior Staff Specialist at Royal Brisbane and Women's Hospital
Bala Venkatesh, MD

Director of Intensive Care at The Wesley Hospital

Bala Venkatesh, MD

Bala Venkatesh, MD

Director of Intensive Care at The Wesley Hospital

Director of Intensive Care at The Wesley Hospital
John Myburgh, AO MD PhD

Intensive Care Physician and clinical researcher

John Myburgh, AO MD PhD

John Myburgh, AO MD PhD

Intensive Care Physician and clinical researcher

Intensive Care Physician and clinical researcher
Eric Bellissant, MD, PhD

Clinical Pharmacologist at Rennes University Hospital

Eric Bellissant, MD, PhD

Eric Bellissant, MD, PhD

Clinical Pharmacologist at Rennes University Hospital

Clinical Pharmacologist at Rennes University Hospital
Karim ASEHNOUNE, MD, PhD

Head of the Anaesthesiology department and Surgical ICU, University hospital of Nantes, France

Karim ASEHNOUNE, MD, PhD

Karim ASEHNOUNE, MD, PhD

Head of the Anaesthesiology department and Surgical ICU, University hospital of Nantes, France

Head of the Anaesthesiology department and Surgical ICU, University hospital of Nantes, France
Djillali Annane, MD

Dean of the School of Medicine Simone Veil at University of Versailles-Paris Saclay

Djillali Annane, MD

Djillali Annane, MD

Dean of the School of Medicine Simone Veil at University of Versailles-Paris Saclay

Dean of the School of Medicine Simone Veil at University of Versailles-Paris Saclay

Faculty Members
Chris Sankey, MD

Associate Program Director in the Traditional Internal Medicine Residency Program & Interim Internal Medicine Clerkship Director at Yale New Haven Hospital

Chris Sankey, MD

Chris Sankey, MD

Associate Program Director in the Traditional Internal Medicine Residency Program & Interim Internal Medicine Clerkship Director at Yale New Haven Hospital

Associate Program Director in the Traditional Internal Medicine Residency Program & Interim Internal Medicine Clerkship Director at Yale New Haven Hospital
Shyoko Honiden, MD, MSc

Associate Professor and Associate Director for the Pulmonary & Critical Care Medicine Fellowship Program at Yale School of Medicine

Shyoko Honiden, MD, MSc

Shyoko Honiden, MD, MSc

Associate Professor and Associate Director for the Pulmonary & Critical Care Medicine Fellowship Program at Yale School of Medicine

Associate Professor and Associate Director for the Pulmonary & Critical Care Medicine Fellowship Program at Yale School of Medicine
Silvio Inzucchi, MD

Professor of Medicine, Program Director of the Endocrinology & Metabolism Fellowship, and Clinical Director of Endocrinology at Yale School of Medicine

Silvio Inzucchi, MD

Silvio Inzucchi, MD

Professor of Medicine, Program Director of the Endocrinology & Metabolism Fellowship, and Clinical Director of Endocrinology at Yale School of Medicine

Professor of Medicine, Program Director of the Endocrinology & Metabolism Fellowship, and Clinical Director of Endocrinology at Yale School of Medicine

Chief Residents
Thomas McCarty, MD

Chief Internal Medicine Resident at Yale-New Haven Hospital

Thomas McCarty, MD

Thomas McCarty, MD

Chief Internal Medicine Resident at Yale-New Haven Hospital

Chief Internal Medicine Resident at Yale-New Haven Hospital
Jacqueline Hirsh, MD

Chief Resident in Internal Medicine at Yale New Haven Hospital

Jacqueline Hirsh, MD

Jacqueline Hirsh, MD

Chief Resident in Internal Medicine at Yale New Haven Hospital

Chief Resident in Internal Medicine at Yale New Haven Hospital
Chris Morton

Chief Resident in Internal Medicine at Yale New Haven Hospital

Chris Morton

Chris Morton

Chief Resident in Internal Medicine at Yale New Haven Hospital

Chief Resident in Internal Medicine at Yale New Haven Hospital

Residents
Devika Kir

Resident in Internal Medicine at Yale Internal Medicine

Devika Kir

Devika Kir

Resident in Internal Medicine at Yale Internal Medicine

Resident in Internal Medicine at Yale Internal Medicine
Hiam Naiditch, MD

Resident at Yale-New Haven Hospital

Hiam Naiditch, MD

Hiam Naiditch, MD

Resident at Yale-New Haven Hospital

Resident at Yale-New Haven Hospital
Merilyn Varghese, MD

Chief Resident in Internal Medicine at Yale New Haven Hospital

Merilyn Varghese, MD

Merilyn Varghese, MD

Chief Resident in Internal Medicine at Yale New Haven Hospital

Chief Resident in Internal Medicine at Yale New Haven Hospital
John Huston, MD

Resident in Internal Medicine at Yale New Haven Hospital

John Huston, MD

John Huston, MD

Resident in Internal Medicine at Yale New Haven Hospital

Resident in Internal Medicine at Yale New Haven Hospital
Daria Madeeva

Resident in Internal Medicine at Yale New Haven Hospital

Daria Madeeva

Daria Madeeva

Resident in Internal Medicine at Yale New Haven Hospital

Resident in Internal Medicine at Yale New Haven Hospital

All Questions & Answers
Question: Based upon the mortality findings in the ADRENAL trial, do you routinely...

NEJM Resident 360 · Discussion

@NEJMres360 Journal Club: Hosted by Yale University Internal Medicine Residency Program on Adjunctive Glucocorticoid Therapy in Patients with Septic Shock, and Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

New Haven, CT
Yale University School of Medicine